Turn Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	5.08	0.87	1.18	2.1
Cash & Short-Term Investments	5.08	0.87	1.18	2.1
Cash Growth	481.73%	-26.11%	-43.84%	-
Prepaid Expenses	0.12	0.23	0.02	0.02
Total Current Assets	5.2	1.1	1.2	2.13
Property, Plant & Equipment	0.08	0.12	0.03	0.08
Other Intangible Assets	0.92	0.82	0.77	0.7
Long-Term Deferred Charges	5.96	-	-	-
Other Long-Term Assets	0.01	0.01	0.01	0.01
Total Assets	12.16	2.05	2.01	2.91
Accounts Payable	2.93	0.67	0.46	0.26
Current Portion of Leases	0.05	0.04	0.03	0.05
Current Unearned Revenue	-	-	-	1.42
Other Current Liabilities	3.03	-	-	-
Total Current Liabilities	6	0.71	0.49	1.72
Long-Term Leases	0.03	0.08	-	0.03
Long-Term Unearned Revenue	1.44	1.44	1.44	-
Total Liabilities	7.48	2.23	1.93	1.76
Common Stock	0	0	0	0
Additional Paid-In Capital	28.14	19.02	17.51	18.37
Retained Earnings	-22.39	-19.2	-17.43	-17.22
Comprehensive Income & Other	-1.07	-	-	-
Shareholders' Equity	4.69	-0.18	0.09	1.16
Total Liabilities & Equity	12.16	2.05	2.01	2.91
Total Debt	0.08	0.12	0.03	0.08
Net Cash (Debt)	5	0.75	1.16	2.02
Net Cash Growth	564.72%	-34.98%	-42.76%	-
Net Cash Per Share	0.18	0.03	0.04	-
Filing Date Shares Outstanding	29.79	26.85	26.49	-
Total Common Shares Outstanding	29.45	26.85	26.49	-
Working Capital	-0.81	0.39	0.71	0.4
Book Value Per Share	0.16	-0.01	0.00	-
Tangible Book Value	3.76	-1	-0.68	0.46
Tangible Book Value Per Share	0.13	-0.04	-0.03	-
Machinery	-	-	-	0.01

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q